Indicator summary: Neutral (2 bullish, 2 bearish, 1 neutral). As of 2026-10-16, the close was $121.47: 2.1% above the 50-day average and 0.9% below the 200-day average, which is rising. RSI (14) is 67, in its neutral range. MACD is bullish after a cross in the last 10 days. The stock sits 49% of the way up its 52-week range of $111.00 to $132.16, on 0.9x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $118.95 | Price 2.1% above |
| 200-day average | $122.54 | Price 0.9% below, average rising |
| 50 vs 200-day | 50 below 200 | Death-cross alignment |
| RSI (14) | 67 | Neutral range |
| MACD (12, 26, 9) | +0.23 vs -0.69 | Bullish cross in the last 10 days |
| 52-week range | $111.00 to $132.16 | 49% of the way up the range |
| Volume vs 20-day average | 0.9x | Normal |
Base rates use DUK's own daily history since 1999; they describe the past, not a forecast.
As of 2026-10-16, DUK's 14-day RSI is 67, which is in the neutral range between 30 and 70.
No. DUK closed at $121.47 on 2026-10-16, 0.9% below its 200-day average of $122.54, which is rising. When it closed below its 200-day average (1,894 days), it was higher 63 trading days later 60% of the time, median +2.3%.
Yes. DUK closed at $121.47 on 2026-10-16, 2.1% above its 50-day average of $118.95. When it closed above its 50-day average (4,203 days), it was higher 63 trading days later 62% of the time, median +2.6%.
Yes, a bullish cross within the last 10 trading days. As of 2026-10-16 the MACD line is +0.23 against a signal line of -0.69, so MACD is bullish.
No. At $121.47 it sits 49% of the way up its 52-week range of $111.00 to $132.16, 8.1% below the high.
Neutral: 2 of 5 indicators are bullish and 2 bearish as of 2026-10-16 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Bearish, from the chart signal model.
DUK analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.